Envita Patient Recounts Her Journey from Terminal to Normal on Fox News
She was given only months to live, but Tammy Morrow, a stage 4 breast cancer patient, found a way out of this grim prognosis. “In just 21 weeks, my diagnosis changed from terminal to normal,” she said, in an article published by Fox News. This 55-year-old Arizona mother and teacher feels so grateful about the care she received at Envita Medical Centers, that she wishes a similar recovery journey for every cancer patient.
"I am persuaded that I would not be alive today if I had not received care at Envita," she added. Tammy explained how the custom-developed comprehensive treatment protocols, including proprietary treatments like GTFC™ (Genetically Targeted Fractionated Chemotherapy) were a gamechanger. Envita's proprietary treatments are based on the innovative personalized precision integrative oncology approach, which combines the latest in conventional medicine with research-based natural therapies to target the cancerous cells and reactivate the immune system.
Envita's specially trained team of physicians, custom develop treatment protocols for each individual patient based on a detailed analysis of their genomics, proteomics, and various other factors. This deep dive into the root cause of each patient's cancer enables them to not just precisely target the cancerous cells, but also strengthen the immune system for sustaining lasting outcomes. Due to its unique approach, this Center of Excellence for precision integrative oncology has been seeing many patients from outside the state, and even from other parts of the world.
In her bid to help more cancer patients experience the kind of recovery that she experienced Tammy does not hesitate to open the doors of her home for those out-of-town patients, who need the care. To know more about Tammy's remarkable journey to recovery and Envita's innovative treatments, explained by doctors, read this article titled “Breast cancer patient says new type of chemo saved her life: 'I am thriving.'”
